The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry.
Call ID: H2020-JTI-IMI2-2018-14-two-stage
Topics
• Topic 1: Targeted immune intervention for the management of non-response and relapse
• Topic 2: Non-invasive clinical molecular imaging of immune cells
• Topic 4: Centre of excellence – remote decentralised clinical trials
Stage 1 submission deadline: 14 June 2018
Read on: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-14